{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:52:27Z","timestamp":1791827547366,"version":"4.3.4"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T00:00:00Z","timestamp":1787529600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1007\/s10072-026-09343-3","type":"journal-article","created":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T03:08:33Z","timestamp":1787540913000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A cerebrospinal fluid blood\u2013brain barrier dysfunction score is associated with progression from mild cognitive impairment to Alzheimer's disease"],"prefix":"10.1007","volume":"47","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-1696-3402","authenticated-orcid":false,"given":"Jing","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,24]]},"reference":[{"issue":"3","key":"9343_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.pharmr.2025.100052","volume":"77","author":"YA Divecha","year":"2025","unstructured":"Divecha YA, Rampes S, Tromp S, Boyanova ST, Fleckney A, Fidanboylu M, Thomas SA (2025) The microcirculation, the blood-brain barrier, and the neurovascular unit in health and Alzheimer disease: the aberrant pericyte is a central player. Pharmacol Rev 77(3):100052","journal-title":"Pharmacol Rev"},{"key":"9343_CR2","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.neurobiolaging.2016.06.006","volume":"45","author":"HJ van de Haar","year":"2016","unstructured":"van de Haar HJ, Jansen JFA, van Osch MJP, van Buchem MA, Muller M, Wong SM, Hofman PAM, Burgmans S, Verhey FRJ, Backes WH (2016) Neurovascular unit impairment in early Alzheimer\u2019s disease measured with magnetic resonance imaging. Neurobiol Aging 45:190\u2013196","journal-title":"Neurobiol Aging"},{"issue":"7","key":"9343_CR3","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1038\/nrn.2017.48","volume":"18","author":"K Kisler","year":"2017","unstructured":"Kisler K, Nelson AR, Montagne A, Zlokovic BV (2017) Cerebral blood flow regulation and neurovascular dysfunction in Alzheimer disease. Nat Rev Neurosci 18(7):419\u2013434","journal-title":"Nat Rev Neurosci"},{"issue":"1","key":"9343_CR4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1152\/physrev.00050.2017","volume":"99","author":"MD Sweeney","year":"2019","unstructured":"Sweeney MD, Zhao Z, Montagne A, Nelson AR, Zlokovic BV (2019) Blood-brain barrier: from physiology to disease and back. Physiol Rev 99(1):21\u201378","journal-title":"Physiol Rev"},{"issue":"2","key":"9343_CR5","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","volume":"25","author":"DA Nation","year":"2019","unstructured":"Nation DA, Sweeney MD, Montagne A, Sagare AP, D\u2019Orazio LM, Pachicano M, Sepehrband F, Nelson AR, Buennagel DP, Harrington MG, Benzinger TLS, Fagan AM, Ringman JM, Schneider LS, Morris JC, Chui HC, Law M, Toga AW, Zlokovic BV (2019) Blood-brain barrier breakdown is an early biomarker of human cognitive dysfunction. Nat Med 25(2):270\u2013276","journal-title":"Nat Med"},{"issue":"3","key":"9343_CR6","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","volume":"14","author":"MD Sweeney","year":"2018","unstructured":"Sweeney MD, Sagare AP, Zlokovic BV (2018) Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders. Nat Rev Neurol 14(3):133\u2013150","journal-title":"Nat Rev Neurol"},{"issue":"11","key":"9343_CR7","doi-asserted-by":"publisher","first-page":"3151","DOI":"10.1084\/jem.20171406","volume":"214","author":"A Montagne","year":"2017","unstructured":"Montagne A, Zhao Z, Zlokovic BV (2017) Alzheimer\u2019s disease: a matter of blood-brain barrier dysfunction? J Exp Med 214(11):3151\u20133169","journal-title":"J Exp Med"},{"issue":"8","key":"9343_CR8","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70402","volume":"21","author":"AR Zimmer","year":"2025","unstructured":"Zimmer AR, Bourourou M, Lesage F, Hamel E (2025) Neurovascular coupling and functional connectivity changes through the Alzheimer\u2019s disease spectrum: effects of simvastatin treatment. Alzheimers Dement 21(8):e70402","journal-title":"Alzheimers Dement"},{"issue":"s1","key":"9343_CR9","doi-asserted-by":"publisher","first-page":"S335","DOI":"10.3233\/JAD-221064","volume":"94","author":"W Huang","year":"2023","unstructured":"Huang W, Xia Q, Zheng F, Zhao X, Ge F, Xiao J, Liu Z, Shen Y, Ye K, Wang D, Li Y (2023) Microglia-mediated neurovascular unit dysfunction in Alzheimer\u2019s disease. J Alzheimers Dis 94(s1):S335-s354","journal-title":"J Alzheimers Dis"},{"issue":"1","key":"9343_CR10","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s13024-025-00798-0","volume":"20","author":"S Chaudhuri","year":"2025","unstructured":"Chaudhuri S, Cho M, Stumpff JC, Bice PJ, \u0130\u015f \u00d6, Ertekin-Taner N, Saykin AJ, Nho K (2025) Cell-specific transcriptional signatures of vascular cells in Alzheimer\u2019s disease: perspectives, pathways, and therapeutic directions. Mol Neurodegener 20(1):12","journal-title":"Mol Neurodegener"},{"issue":"12","key":"9343_CR11","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1038\/nrn3114","volume":"12","author":"BV Zlokovic","year":"2011","unstructured":"Zlokovic BV (2011) Neurovascular pathways to neurodegeneration in Alzheimer\u2019s disease and other disorders. Nat Rev Neurosci 12(12):723\u2013738","journal-title":"Nat Rev Neurosci"},{"issue":"6","key":"9343_CR12","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1038\/s41593-023-01334-3","volume":"26","author":"N Sun","year":"2023","unstructured":"Sun N, Akay LA, Murdock MH, Park Y, Galiana-Melendez F, Bubnys A, Galani K, Mathys H, Jiang X, Ng AP, Bennett DA, Tsai LH, Kellis M (2023) Single-nucleus multiregion transcriptomic analysis of brain vasculature in Alzheimer\u2019s disease. Nat Neurosci 26(6):970\u2013982","journal-title":"Nat Neurosci"},{"key":"9343_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.biomaterials.2024.122864","volume":"314","author":"G Pavlou","year":"2025","unstructured":"Pavlou G, Spitz S, Pramotton FM, Tsai A, Li BM, Wang X, Barr OM, Ko EC, Zhang S, Ashley SJ, Maaser-Hecker A, Choi SH, Jorfi M, Tanzi RE, Kamm RD (2025) Engineered 3D human neurovascular model of Alzheimer\u2019s disease to study vascular dysfunction. Biomaterials 314:122864","journal-title":"Biomaterials"},{"issue":"1","key":"9343_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0670-z","volume":"13","author":"BW Festoff","year":"2016","unstructured":"Festoff BW, Sajja RK, van Dreden P, Cucullo L (2016) HMGB1 and thrombin mediate the blood-brain barrier dysfunction acting as biomarkers of neuroinflammation and progression to neurodegeneration in Alzheimer\u2019s disease. J Neuroinflammation 13(1):194","journal-title":"J Neuroinflammation"},{"key":"9343_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.pneurobio.2020.101904","volume":"198","author":"S Ayton","year":"2021","unstructured":"Ayton S, Janelidze S, Roberts B, Palmqvist S, Kalinowski P, Diouf I, Belaidi AA, Stomrud E, Bush AI, Hansson O (2021) Acute phase markers in CSF reveal inflammatory changes in Alzheimer\u2019s disease that intersect with pathology, APOE \u03b54, sex and age. Prog Neurobiol 198:101904","journal-title":"Prog Neurobiol"},{"issue":"1","key":"9343_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13195-024-01529-1","volume":"16","author":"L Preis","year":"2024","unstructured":"Preis L, Villringer K, Brosseron F, D\u00fczel E, Jessen F, Petzold GC, Ramirez A, Spottke A, Fiebach JB, Peters O (2024) Assessing blood-brain barrier dysfunction and its association with Alzheimer\u2019s pathology, cognitive impairment and neuroinflammation. Alzheimers Res Ther 16(1):172","journal-title":"Alzheimers Res Ther"},{"issue":"11","key":"9343_CR17","doi-asserted-by":"publisher","DOI":"10.1002\/alz.70830","volume":"21","author":"MC Bangs","year":"2025","unstructured":"Bangs MC, Gadhavi J, Carter EK, Ping L, Duong DM, Dammer EB, Wu F, Shantaraman A, Fox EJ, Johnson ECB, Lah JJ, Levey AI, Seyfried NT (2025) Proteomic subtyping of Alzheimer\u2019s disease CSF links blood-brain barrier dysfunction to reduced levels of tau and synaptic biomarkers. Alzheimers Dement 21(11):e70830","journal-title":"Alzheimers Dement"},{"key":"9343_CR18","doi-asserted-by":"crossref","unstructured":"Jack, Jr. CR, Bernstein MA, Fox NC, Thompson P, Alexander G, Harvey D, Borowski B, Britson PJ, W JL, Ward C,Dale AM, Felmlee JP, Gunter JL, Hill DL, Killiany R, Schuff N, Fox-Bosetti S, Lin C, Studholme C, DeCarli CS, Krueger G, Ward HA, Metzger GJ, Scott KT, Mallozzi R, Blezek D, Levy J, Debbins JP, Fleisher AS, Albert M, Green R, Bartzokis G, Glover G, Mugler J, Weiner MW (2008) The Alzheimer's Disease Neuroimaging Initiative (ADNI): MRI methods. J Magn Reson Imaging 27(4):685\u201391","DOI":"10.1002\/jmri.21049"},{"issue":"9","key":"9343_CR19","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.1038\/s41593-021-00886-6","volume":"24","author":"C Yang","year":"2021","unstructured":"Yang C, Farias FHG, Ibanez L, Suhy A, Sadler B, Fernandez MV, Wang F, Bradley JL, Eiffert B, Bahena JA, Budde JP, Li Z, Dube U, Sung YJ, Mihindukulasuriya KA, Morris JC, Fagan AM, Perrin RJ, Benitez BA, Rhinn H, Harari O, Cruchaga C (2021) Genomic atlas of the proteome from brain, CSF and plasma prioritizes proteins implicated in neurological disorders. Nat Neurosci 24(9):1302\u20131312","journal-title":"Nat Neurosci"},{"key":"9343_CR20","doi-asserted-by":"crossref","unstructured":"Kurki MI, Karjalainen J, Palta P, Sipil\u00e4 TP, Kristiansson K, Donner KM, Reeve MP, Laivuori H, Aavikko M, Kaunisto MA, Loukola A, Lahtela E, Mattsson H, Laiho P, Della Briotta Parolo P, Lehisto AA, Kanai M, Mars N, R\u00e4m\u00f6 J, Kiiskinen T, Heyne HO, Veerapen K, R\u00fceger S, Lemmel\u00e4 S, Zhou W, Ruotsalainen S, P\u00e4rn K, Hiekkalinna T, Koskelainen S, Paajanen T, Llorens V, Gracia-Tabuenca J, Siirtola H, Reis K, Elnahas AG, Sun B, Foley CN, Aalto-Set\u00e4l\u00e4 K, Alasoo K, Arvas M, Auro K, Biswas S, Bizaki-Vallaskangas A, Carpen O, Chen CY, Dada OA, Ding Z, Ehm MG, Eklund K, F\u00e4rkkil\u00e4 M, Finucane H, Ganna A, Ghazal A, Graham RR, Green EM, Hakanen A, Hautalahti M, Hedman \u00c5 K, Hiltunen M, Hinttala R, Hovatta I, Hu X, Huertas-Vazquez A, Huilaja L, Hunkapiller J, Jacob H, Jensen JN, Joensuu H, John S, Julkunen V, Jung M, Junttila J, Kaarniranta K, K\u00e4h\u00f6nen M, Kajanne R, Kallio L, K\u00e4lvi\u00e4inen R, Kaprio J, Kerimov N, Kettunen J, Kilpel\u00e4inen E, Kilpi T, Klinger K, Kosma VM, Kuopio T, Kurra V, Laisk T, Laukkanen J, Lawless N, Liu A, Longerich S, M\u00e4gi R, M\u00e4kel\u00e4 J, M\u00e4kitie A, Malarstig A, Mannermaa A, Maranville J, Matakidou A, Meretoja T, Mozaffari SV, Niemi MEK, Niemi M, Niiranen T, CJ OD, Obeidat ME, Okafo G, Ollila HM, Palom\u00e4ki A, Palotie T, Partanen J, Paul DS, Pelkonen M, Pendergrass RK, Petrovski S, Pitk\u00e4ranta A, Platt A, Pulford D, Punkka E, Pussinen P, Raghavan N, Rahimov F, Rajpal D, Renaud NA, Riley-Gillis B, Rodosthenous R, Saarentaus E, Salminen A, Salminen E, Salomaa V, Schleutker J, Serpi R, Shen HY, Siegel R, Silander K, Siltanen S, Soini S, Soininen H, Sul JH, Tachmazidou I, Tasanen K, Tienari P, Toppila-Salmi S, Tukiainen T, Tuomi T, Turunen JA, Ulirsch JC, Vaura F, Virolainen P, Waring J, Waterworth D, Yang R, Nelis M, Reigo A, Metspalu A, Milani L, Esko T, Fox C, Havulinna AS, Perola M, Ripatti S, Jalanko A, Laitinen T, M\u00e4kel\u00e4 TP, Plenge R, McCarthy M, Runz H, Daly MJ, Palotie A (2023) FinnGen provides genetic insights from a well-phenotyped isolated population. Nature 613(7944):508\u2013518","DOI":"10.1038\/s41586-022-05473-8"},{"issue":"2","key":"9343_CR21","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1093\/ije\/dyv080","volume":"44","author":"J Bowden","year":"2015","unstructured":"Bowden J, Davey Smith G, Burgess S (2015) Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol 44(2):512\u2013525","journal-title":"Int J Epidemiol"},{"issue":"4","key":"9343_CR22","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/gepi.21965","volume":"40","author":"J Bowden","year":"2016","unstructured":"Bowden J, Davey Smith G, Haycock PC, Burgess S (2016) Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol 40(4):304\u2013314","journal-title":"Genet Epidemiol"},{"key":"9343_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.archger.2024.105441","volume":"124","author":"X Tian","year":"2024","unstructured":"Tian X, Zhao Y, Zhu Y, Cui M (2024) Association between elevated blood-brain barrier permeability and the risk of progressive cognitive decline: a longitudinal study. Arch Gerontol Geriatr 124:105441","journal-title":"Arch Gerontol Geriatr"},{"key":"9343_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijbiomac.2024.139394","volume":"294","author":"S Wang","year":"2025","unstructured":"Wang S, Xi J, Zhang M, Wang J (2025) Identification of potential therapeutic targets for Alzheimer\u2019s disease from the proteomes of plasma and cerebrospinal fluid in a multicenter Mendelian randomization study. Int J Biol Macromol 294:139394","journal-title":"Int J Biol Macromol"},{"key":"9343_CR25","doi-asserted-by":"publisher","first-page":"564","DOI":"10.3389\/fcell.2020.00564","volume":"8","author":"Z Huang","year":"2020","unstructured":"Huang Z, Qi G, Miller JS, Zheng SG (2020) CD226: an emerging role in immunologic diseases. Front Cell Dev Biol 8:564","journal-title":"Front Cell Dev Biol"},{"key":"9343_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/biom15071007","author":"K Liu","year":"2025","unstructured":"Liu K, Liu Y, Xiong H, Ning Z (2025) The immune regulatory functions of CD226 and its implications in immune-mediated diseases. Biomolecules. https:\/\/doi.org\/10.3390\/biom15071007","journal-title":"Biomolecules"},{"key":"9343_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2022.106404","volume":"184","author":"A Yousefizadeh","year":"2022","unstructured":"Yousefizadeh A, Piccioni G, Saidi A, Triaca V, Mango D, Nistic\u00f2 R (2022) Pharmacological targeting of microglia dynamics in Alzheimer\u2019s disease: preclinical and clinical evidence. Pharmacol Res 184:106404","journal-title":"Pharmacol Res"},{"issue":"6","key":"9343_CR28","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1177\/13524585241234489","volume":"30","author":"S Kari","year":"2024","unstructured":"Kari S, Bucciarelli F, Angles T, Oster AC, Cauboue P, Laviolette K, Mougenot M, Morandi E, Bernard I, Pignolet B, Bost C, Thomas J, Nogueira L, Saoudi A, Liblau R, Astier AL (2024) Increased levels of circulating soluble CD226 in multiple sclerosis. Mult Scler 30(6):654\u2013663","journal-title":"Mult Scler"},{"issue":"1","key":"9343_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/mol.119.118950","volume":"98","author":"S Jmaeff","year":"2020","unstructured":"Jmaeff S, Sidorova Y, Lippiatt H, Barcelona PF, Nedev H, Saragovi LM, Hancock MA, Saarma M, Saragovi HU (2020) Small-molecule ligands that bind the RET receptor activate neuroprotective signals independent of but modulated by coreceptor GFR\u03b11. Mol Pharmacol 98(1):1\u201312","journal-title":"Mol Pharmacol"},{"issue":"1","key":"9343_CR30","doi-asserted-by":"publisher","first-page":"7551","DOI":"10.1038\/s41467-023-43148-8","volume":"14","author":"FM Houghton","year":"2023","unstructured":"Houghton FM, Adams SE, R\u00edos AS, Masino L, Purkiss AG, Briggs DC, Ledda F, McDonald NQ (2023) Architecture and regulation of a GDNF-GFR\u03b11 synaptic adhesion assembly. Nat Commun 14(1):7551","journal-title":"Nat Commun"},{"issue":"12","key":"9343_CR31","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1038\/s41588-024-01972-8","volume":"56","author":"D Western","year":"2024","unstructured":"Western D, Timsina J, Wang L, Wang C, Yang C, Phillips B, Wang Y, Liu M, Ali M, Beric A, Gorijala P, Kohlfeld P, Budde J, Levey AI, Morris JC, Perrin RJ, Ruiz A, Marqui\u00e9 M, Boada M, de Rojas I, Rutledge J, Oh H, Wilson EN, Le Guen Y, Reus LM, Tijms B, Visser PJ, van der Lee SJ, Pijnenburg YAL, Teunissen CE, Del Campo Milan M, Alvarez I, Aguilar M, Greicius MD, Pastor P, Pulford DJ, Ibanez L, Wyss-Coray T, Sung YJ, Cruchaga C (2024) Proteogenomic analysis of human cerebrospinal fluid identifies neurologically relevant regulation and implicates causal proteins for Alzheimer\u2019s disease. Nat Genet 56(12):2672\u20132684","journal-title":"Nat Genet"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10072-026-09343-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-026-09343-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T17:34:08Z","timestamp":1791826448000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10072-026-09343-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,24]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["9343"],"URL":"https:\/\/doi.org\/10.1007\/s10072-026-09343-3","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,24]]},"assertion":[{"value":"19 May 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author declare no competing interests related to this work.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ADNI study was approved by the Institutional Review Boards of all participating institutions, and all procedures were conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","label":"Ethics approval","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Written informed consent was obtained from all ADNI participants or their authorized representatives prior to data collection.","order":3,"name":"Ethics","label":"Consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":4,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"729"}}